Phase I dose escalation and pharmacokinetic study of oral gefitinib and irinotecan in children with refractory solid tumors
Crossref DOI link: https://doi.org/10.1007/s00280-014-2593-7
Published Online: 2014-09-26
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Brennan, R. C.
Furman, W.
Mao, S.
Wu, J.
Turner, D. C.
Stewart, C. F.
Santana, V.
McGregor, L. M.
Text and Data Mining valid from 2014-09-26